<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2024-1-66-76</article-id><article-id custom-type="edn" pub-id-type="custom">AQCTAJ</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПОИСК НОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEW DRUGS DISCOVERY</subject></subj-group></article-categories><title-group><article-title>Фармакоинформационные, фундаментальные и клинические исследования 7-гидроксиматаирезинола в контексте поиска эффективных и безопасных терапевтических подходов к лечению мастопатии</article-title><trans-title-group xml:lang="en"><trans-title>Pharmacoinformational, basic and clinical studies of 7-hydroxymatairesinol in the context of searching for effective and safe therapeutic approaches to the treatment of mastopathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9639-2525</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рубашкина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rubashkina</surname><given-names>А. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рубашкина Анна Николаевна – аспирант</p><p>Иваново</p></bio><bio xml:lang="en"><p>Аnna N. Rubashkina – graduate student </p><p>Ivanovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич – к. ф–м. н., к. х. н., в. н. с.</p><p>Москва</p></bio><bio xml:lang="en"><p>Ivan Yu. Torshin – PhD, Cand. Physico-Mathematical Sci., Cand. Chemical Sci., Leading researcher</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна – д. м. н, профессор, в. н. с. </p><p>Москва</p></bio><bio xml:lang="en"><p>Olga A. Gromova – Dr. Sci. (Med.), Professor, Leading researcher</p><p>Moscow</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBEI HE «Ivanovo State Medical University» of MOH of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр «Информатика и управление» РАН» (ФИЦ ИУ РАН)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FRC «Computer Science and Control» RAS</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>66</fpage><lpage>76</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рубашкина А.Н., Торшин И.Ю., Громова О.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Рубашкина А.Н., Торшин И.Ю., Громова О.А.</copyright-holder><copyright-holder xml:lang="en">Rubashkina А.N., Torshin I.Y., Gromova O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/411">https://www.pharmacokinetica.ru/jour/article/view/411</self-uri><abstract><p>7-гидроксиматаирезинол (7(ОН)МР) – основной лигнан экстрактов ели, характеризующийся онкопротективными и противовоспалительными свойствами. Результаты хемореактомного моделирования позволили сформулировать молекулярные механизмы осуществления фармакологических эффектов 7(ОН)МР для противовоспалительных (ингибирование 5-липоксигеназы, матриксной металлопротеиназы ММР2, митоген-активируемой киназы p38-альфа, рецептора лейкотриена b4, рецептора простациклина), онкопротективных (антиоксидантный эффект за счёт ингибирования гемоксигеназы-2, ингибирование циклин-зависимых киназ 3 и 4, фактора роста эпидермиса, белка mTOR). Оценка транскриптомных эффектов 7(ОН)МР в клетках рака молочной железы показала достоверные дозозависимые эффекты на транскрипцию 3468 из 12700 генов. Молекула 7(ОН)МР, снижая экспрессию пролиферативных генов (401 ген) и хроническое воспаление (148 генов), параллельно повышая транкрипцию генов онкопротективного иммунитета (100 генов), тормозит пролиферацию опухолевых клеток. Эксперименты на солидной карциноме Эрлиха показали достоверный онко- протективный эффект 7(ОН)МР в дозах 60, 120 мг/сут, даже на фоне приёма эстрогенов (p = 0,007). Клиническое исследование показало, что 7(ОН)МР (60 мг/сут, 1 мес.) способствует нормализации метаболизма эстрогенов (МЭ) и улучшению клинической симптоматики мастопатии.</p></abstract><trans-abstract xml:lang="en"><p>7-hydroxymatairesinol (7(OH)MR) is the main lignan of spruce extracts, characterized by oncoprotective and anti-inflammatory properties. The results of chemoreactome modeling made it possible to formulate the molecular mechanisms of the pharmacological effects of 7(OH)MR for anti-inflammatory (inhibition of 5-lipoxygenase, matrix metalloproteinase MMP2, mitogen-activated kinase p38-alpha, leukotriene b4 receptor, prostacyclin receptor), oncoprotective (antioxidant effect due to inhibition heme oxygenase-2, inhibition of cyclin-dependent kinases 3 and 4, epidermal growth factor, mTOR protein). An assessment of the transcriptomic effects of 7(OH)MR in breast cancer cells showed significant dose-dependent effects on the transcription of 3468 of 12700 genes. The 7(OH)MR molecule, reducing the expression of proliferative genes (401 genes) and chronic inflammation (148 genes), while simultaneously increasing the transcription of oncoprotective immunity genes (100 genes), inhibits the proliferation of tumor cells. Experiments on solid Ehrlich carcinoma showed a significant oncoprotective effect of 7(OH)MR at doses of 60, 120 mg/day, even while taking estrogen (p = 0.007). A clinical study showed that 7(OH)MR (60 mg/day, 1 month) helps normalize estrogen metabolism and improve the clinical symptoms of mastopathy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мастопатия</kwd><kwd>лигнаны</kwd><kwd>патогенетическая терапия</kwd><kwd>фармакоинформатика</kwd><kwd>протеом человека</kwd><kwd>транскриптомика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mastopathy</kwd><kwd>lignans</kwd><kwd>pathogenetic therapy</kwd><kwd>pharmacoinformatics</kwd><kwd>human proteome</kwd><kwd>transcriptomics</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена по гранту Российского научного фонда (проект № 23-21-00154).</funding-statement><funding-statement xml:lang="en">This work was supported by a grant from the Russian Science Foundation (project № 23-21-00154).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gerstenmeyer E, Reimer S, Berghofer E, et al. Effect of thermal heating on some lignans in flax seeds, sesame seeds and rye. Food Chem. 2013 Jun 1;138(2-3):1847-55. doi: 10.1016/j.foodchem.2012.11.117.</mixed-citation><mixed-citation xml:lang="en">Gerstenmeyer E, Reimer S, Berghofer E, et al. Effect of thermal heating on some lignans in flax seeds, sesame seeds and rye. Food Chem. 2013 Jun 1;138(2-3):1847-55. doi: 10.1016/j.foodchem.2012.11.117.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Рубашкина А.Н., и др. Систематический анализ фундаментальных и клинических исследований лигнана 7-гидроксиматаирезинола. Эффективная фармакотерапия. 2019;15(13):34-41.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Rubashkina AN, et al. Systematic Analysis of Fundamental and Clinical Studies of Lignan 7-Hydroxymatairesinol. Effective pharmacotherapy. 2019;15(13):34-41. (In Russ.). doi: 10.33978/2307-3586-2019-15-13-34-41.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Udani JK, Brown DJ, Tan MO, Hardy M. Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a singleblinded, parallel, dose-comparison study. J Am Coll Nutr. 2013;32(6):428-35. doi: 10.1080/07315724.2013.849578.</mixed-citation><mixed-citation xml:lang="en">Udani JK, Brown DJ, Tan MO, Hardy M. Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a singleblinded, parallel, dose-comparison study. J Am Coll Nutr. 2013;32(6):428-35. doi: 10.1080/07315724.2013.849578.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lina B, Korte H, Nyman L, Unkila M. A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats. Regul Toxicol Pharmacol. 2005 Feb;41(1):28-38. doi: 10.1016/j.yrtph.2004.09.001.</mixed-citation><mixed-citation xml:lang="en">Lina B, Korte H, Nyman L, Unkila M. A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats. Regul Toxicol Pharmacol. 2005 Feb;41(1):28-38. doi: 10.1016/j.yrtph.2004.09.001.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wolterbeek AP, Roberts A, Korte H, et al. Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats. Regul Toxicol Pharmacol. 2004 Aug;40(1):1-8. doi: 10.1016/j.yrtph.2004.04.001.</mixed-citation><mixed-citation xml:lang="en">Wolterbeek AP, Roberts A, Korte H, et al. Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats. Regul Toxicol Pharmacol. 2004 Aug;40(1):1-8. doi: 10.1016/j.yrtph.2004.04.001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Saarinen NM, Wärri A, Mäkelä SI, et al. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer. 2000;36(2):207-16. doi: 10.1207/S15327914NC3602_10.</mixed-citation><mixed-citation xml:lang="en">Saarinen NM, Wärri A, Mäkelä SI, et al. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer. 2000;36(2):207-16. doi: 10.1207/S15327914NC3602_10.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Журавлёв Ю.И., Рудаков К.В., Торшин И.Ю. Алгебраические критерии локальной разрешимости и регулярности как инструментисследования морфологии аминокислотных последовательностей. Труды МФТИ. 2011;3(4):67-76.</mixed-citation><mixed-citation xml:lang="en">Zhuravlev YuI, Rudakov KV, Torshin IYu. Algebraic criteria of local solvability and regularity as a tool for studying the morphology of amino acid sequences. Proceedings of MIPT. 2011;3(4):67-76. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2014;24(1):11-23. doi: 10.1134/S1054661814010209.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2014;24(1):11-23. doi: 10.1134/S1054661814010209.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognition and Image Analysis. 2010;20(3):386-395. doi: 10.1134/S1054661810030156.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognition and Image Analysis. 2010;20(3):386-395. doi: 10.1134/S1054661810030156.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А. Экспертный анализ данных в молекулярной фармакологии. М.: МЦНМО, 2012. 747 с.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova OA. Expert data analysis in molecular pharmacology. Moscow: Ed. MCNMO, 2012. (In Russ.). ISBN 978-5-4439-0051-3.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Рубашкина А.Н., Лапочкина Н.П., Громова О.А. Хемореактомный анализ 7-гидроксиматаирезинола, 17-эстрадиола, фитоэстрогена β-ситостирола и эпигаллокатехин-3-галлата. Акушерство, Гинекология и Репродукция. 2020;14(3):347-360.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rubashkina AN, Lapochkina NP, Gromova OA. Chemoreactome analysis of 7-hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate. Akusherstvo, Ginekologia i Reprodukcia = Obstetrics, Gynecology and Reproduction. 2020;14(3):347-360. (In Russ.). doi: 10.17749/2313-7347/ob.gyn.rep.2020.152.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А., Фролова Д.Е., Гришина Т.Р., Лапочкина Н.П. Дозозависимый хемотранскриптомный анализ дифференциального действия витамина D на экспрессию генов в клетках-предшественниках нейронов NPC и в опухолевых клетках MCF7 человека. Фармакокинетика и Фармакодинамика. 2018;(2):35-51.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova OA, Frolova DE, Grishina TR, Lapochkina NP. Dose-dependent chemotranscriptomics analysis of the differential effects of vitamin D3 on gene expression in human neuronal progenitor cells NPC and in MCF7 tumor cells. Pharmacokinetics and Pharmacodynamics. 2018;(2):35-51. (In Russ.). doi: 10.24411/2587-7836-2018-10013.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. New York : Nova biomedical books, 2009, ISBN: 978-1-60692-217.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. New York : Nova biomedical books, 2009, ISBN: 978-1-60692-217.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Рубашкина А.Н., Громова О.А. Хемотранскриптомный анализ эффектов молекулы 7-гидроксиматаирезинола на опухолевые клетки молочной железы человека линии MCF7. Акушерство, Гинекология и Репродукция. 2023;17(5):584-596.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rubashkina AN, Gromova OA. Chemotranscriptomic analysis of 7-hydroxymatairesinol-related effects on MCF7 human breast tumor cells. Obstetrics, Gynecology and Reproduction. 2023;17(5):584-596. (In Russ.). doi: 10.17749/2313-7347/ob.gyn.rep.2023.409.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Фролова Д.Е., Торшин И.Ю., и др. Противоопухолевые эффекты витамина В 12 in vitro, in vivo, in silico. ФАРМАКОЭКО-НОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2024: [принятая рукопись].</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Frolova DE, Torshin IYu, et al. Antitumor effects of vitamin B12 in vitro, in vivo, in silico. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoe-pidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2024: [accepted manuscript]. (In Russ.). doi: 10.17749/2070-4909/farmakoekonomika.2024.231.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On metric spaces arising during formalization of problems of recognition and classification. part 2: density properties. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2016;26(3):483-496. doi: 10.1134/S1054661816030202.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On metric spaces arising during formalization of problems of recognition and classification. part 2: density properties. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2016;26(3):483-496. doi: 10.1134/S1054661816030202.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017;27(2):184-199. doi: 10.1134/S1054661817020110.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017;27(2):184-199. doi: 10.1134/S1054661817020110.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cosentino M, Marino F, Maio RC, et al. Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/lignan) extracted from the heartwood of Norway spruce (Picea abies). Int Immunopharmacol. 2010 Mar;10(3):339-43. doi: 10.1016/j.intimp.2009.12.005.</mixed-citation><mixed-citation xml:lang="en">Cosentino M, Marino F, Maio RC, et al. Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/lignan) extracted from the heartwood of Norway spruce (Picea abies). Int Immunopharmacol. 2010 Mar;10(3):339-43. doi: 10.1016/j.intimp.2009.12.005.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Spilioti E, Holmbom B, Papavassiliou AG, Moutsatsou P. Lignans 7-hydroxymatairesinol and 7-hydroxymatairesinol 2 exhibit anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res. 2014 Apr;58(4):749-59. doi: 10.1002/mnfr.201300318.</mixed-citation><mixed-citation xml:lang="en">Spilioti E, Holmbom B, Papavassiliou AG, Moutsatsou P. Lignans 7-hydroxymatairesinol and 7-hydroxymatairesinol 2 exhibit anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res. 2014 Apr;58(4):749-59. doi: 10.1002/mnfr.201300318.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yang D, Xiao CX, Su ZH, Huang MW, Qin M, Wu WJ, Jia WW, Zhu YZ, Hu JF, Liu XH. (-)-7(S)-hydroxymatairesinol protects against tumor necrosis factor-α-mediated inflammation response in endothelial cells by blocking the MAPK/NF-κB and activating Nrf2/HO-1. Phytomedicine. 2017 Aug 15;32:15-23. doi: 10.1016/j.phymed.2017.04.005.</mixed-citation><mixed-citation xml:lang="en">Yang D, Xiao CX, Su ZH, Huang MW, Qin M, Wu WJ, Jia WW, Zhu YZ, Hu JF, Liu XH. (-)-7(S)-hydroxymatairesinol protects against tumor necrosis factor-α-mediated inflammation response in endothelial cells by blocking the MAPK/NF-κB and activating Nrf2/HO-1. Phytomedicine. 2017 Aug 15;32:15-23. doi: 10.1016/j.phymed.2017.04.005.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Samson K. LEE011 CDK Inhibitor Showing Early Promise in Drug-Resistant Cancers. Oncology Times. 2014;36(3):39-40. doi: 10.1097/01.COT.0000444043.33304.c1.</mixed-citation><mixed-citation xml:lang="en">Samson K. LEE011 CDK Inhibitor Showing Early Promise in Drug-Resistant Cancers. Oncology Times. 2014;36(3):39-40. doi: 10.1097/01.COT.0000444043.33304.c1.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Liang W, Wu X, Fang W, et al. Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. PLoS One. 2014 Feb 12;9(2):e85245. doi: 10.1371/journal.pone.0085245.</mixed-citation><mixed-citation xml:lang="en">Liang W, Wu X, Fang W, et al. Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. PLoS One. 2014 Feb 12;9(2):e85245. doi: 10.1371/journal.pone.0085245.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lamming DW, Ye L, Sabatini DM, Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest. 2013 Mar;123(3):980-9. doi: 10.1172/JCI64099. PMID: 23454761.</mixed-citation><mixed-citation xml:lang="en">Lamming DW, Ye L, Sabatini DM, Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest. 2013 Mar;123(3):980-9. doi: 10.1172/JCI64099. PMID: 23454761.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Rogowski M, Gollahon L, Chellini G, Assadi-Porter FM. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells. FEBS Open Bio. 2017 Mar 6;7(4):587-601. doi: 10.1002/2211-5463.12205. Erratum in: FEBS Open Bio. 2017 May 22;7(6):887.</mixed-citation><mixed-citation xml:lang="en">Rogowski M, Gollahon L, Chellini G, Assadi-Porter FM. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells. FEBS Open Bio. 2017 Mar 6;7(4):587-601. doi: 10.1002/2211-5463.12205. Erratum in: FEBS Open Bio. 2017 May 22;7(6):887.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Aouad P, Saikali M, Abdel-Samad R, et al. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anticancer Drugs. 2017 Aug;28(7):757-770. doi: 10.1097/CAD.0000000000000511.</mixed-citation><mixed-citation xml:lang="en">Aouad P, Saikali M, Abdel-Samad R, et al. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anticancer Drugs. 2017 Aug;28(7):757-770. doi: 10.1097/CAD.0000000000000511.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Saarinen NM, Huovinen R, Wärri A, et al. Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer. 2001;41(1-2):82-90. doi: 10.1080/01635581.2001.9680616.</mixed-citation><mixed-citation xml:lang="en">Saarinen NM, Huovinen R, Wärri A, et al. Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer. 2001;41(1-2):82-90. doi: 10.1080/01635581.2001.9680616.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Miura D, Saarinen NM, Miura Y, et al. Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats. Nutr Cancer. 2007;58(1):49-59. doi: 10.1080/01635580701308133.</mixed-citation><mixed-citation xml:lang="en">Miura D, Saarinen NM, Miura Y, et al. Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats. Nutr Cancer. 2007;58(1):49-59. doi: 10.1080/01635580701308133.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bylund A, Saarinen N, Zhang JX, et al. Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med (Maywood). 2005 Mar;230(3):217-23. doi: 10.1177/153537020523000308.</mixed-citation><mixed-citation xml:lang="en">Bylund A, Saarinen N, Zhang JX, et al. Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med (Maywood). 2005 Mar;230(3):217-23. doi: 10.1177/153537020523000308.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Katsuda S, Yoshida M, Saarinen N, et al. Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats. Exp Biol Med (Maywood). 2004 May;229(5):417-24. doi: 10.1177/153537020422900510.</mixed-citation><mixed-citation xml:lang="en">Katsuda S, Yoshida M, Saarinen N, et al. Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats. Exp Biol Med (Maywood). 2004 May;229(5):417-24. doi: 10.1177/153537020422900510.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Oikarinen SI, Pajari A, Mutanen M. Chemopreventive activity of crude hydroxsymatairesinol (HMR) extract in Apc(Min) mice. Cancer Lett. 2000 Dec 20;161(2):253-8. doi: 10.1016/s0304-3835(00)00662-5.</mixed-citation><mixed-citation xml:lang="en">Oikarinen SI, Pajari A, Mutanen M. Chemopreventive activity of crude hydroxsymatairesinol (HMR) extract in Apc(Min) mice. Cancer Lett. 2000 Dec 20;161(2):253-8. doi: 10.1016/s0304-3835(00)00662-5.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Рубашкина А.Н., Лапочкина Н.П., Торшин И.Ю., Громова О.А. Роль 7-гидроксиматаирезинола в модуляции метаболизма эстрогенов и терапии мастопатии. Гинекология. 2020;22(4):43-48.</mixed-citation><mixed-citation xml:lang="en">Rubashkina AN, Lapochkina NP, Torshin IYu, Gromova OA. The role of 7-hydroxymatairezinol in modulation of estrogen metabolism and therapy for mastopathy. Gynecology. 2020;22(4):43-48. (In Russ.). doi: 10.26442/20795696.2020.4.200183.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kangas L, Saarinen N, Mutanen M, et al. Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce. Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S48-57.</mixed-citation><mixed-citation xml:lang="en">Kangas L, Saarinen N, Mutanen M, et al. Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce. Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S48-57.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Britschgi A, Duss S, Kim S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017 Jan 26;541(7638):541-545. doi: 10.1038/nature20829.</mixed-citation><mixed-citation xml:lang="en">Britschgi A, Duss S, Kim S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017 Jan 26;541(7638):541-545. doi: 10.1038/nature20829.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YF, Young WJ, Lin WJ, Shyr CR, Chang C. Differential regulation of direct repeat 3 vitamin D3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor. J Biol Chem. 1999 Jun 4;274(23):16198-205. doi: 10.1074/jbc.274.23.16198.</mixed-citation><mixed-citation xml:lang="en">Lee YF, Young WJ, Lin WJ, Shyr CR, Chang C. Differential regulation of direct repeat 3 vitamin D3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor. J Biol Chem. 1999 Jun 4;274(23):16198-205. doi: 10.1074/jbc.274.23.16198.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">van Agthoven T, van Agthoven TL, Dekker A, et al. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 1998 May 15;17(10):2799-808. doi: 10.1093/emboj/17.10.2799.</mixed-citation><mixed-citation xml:lang="en">van Agthoven T, van Agthoven TL, Dekker A, et al. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 1998 May 15;17(10):2799-808. doi: 10.1093/emboj/17.10.2799.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
